Which sedative is safer for High-Risk ERCP patients?
NCT ID NCT07166614
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two sedatives, dexmedetomidine and propofol, in 100 high-risk patients undergoing ERCP. The goal was to see which drug causes fewer breathing and heart problems. Researchers monitored vital signs closely to find the safer option for these vulnerable patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sisli etfal research and training hospital
Sarıyer, Istanbul, 34371, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nasal cannula outperform a face mask in keeping patients oxygenated during emergency intubation?
- Brain oxygen showdown: nasal cannula vs face mask during sedation
- Global study aims to uncover why lifesaving oxygen often fails to reach patients
- Pacemaker tweak may also lower blood pressure
- Could a pacemaker tame stubborn high blood pressure?
- Freezing or burning heart nerves: which works best for slow heartbeat?